<DOC>
	<DOCNO>NCT02108990</DOCNO>
	<brief_summary>Recent research identify heighten sensitivity social rejection core feature BPD . Rejection sensitivity trigger aggressive , impulsive , self-injurious behavior characteristic disorder . Therefore target therapy towards reduction rejection sensitivity may improve low rate effectiveness current pharmacological behavioral therapy . Therefore , proposal test theoretically-based pharmacological approach specifically target heighten sensitivity rejection experience BPD patient . In prior research normal control , show chronic treatment physical pain-killer acetaminophen ( e.g . Tylenol ) reduce neural response social rejection ( use fMRI ) well self-reported feeling rejection daily diary study . It aim research project determine over-the-counter analgesic , acetaminophen ( active ingredient Tylenol ) , reduce symptom behavior BPD patient . The goal proposal use open-label design determine acetaminophen improve symptom BPD patient .</brief_summary>
	<brief_title>Acetaminophen Social Processes</brief_title>
	<detailed_description />
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>clinical diagnosis borderline personality disorder 18 year old psychiatric medication , must stable dose able swallow tablet current , primary substance abuse , particularly alcoholism current eating disorder history current psychotic disorder suicidal ideation behavior require imminent inpatient treatment pregnancy Participants whose medication stable 4 week Impaired liver function ( &gt; 1.25x upper limit reference range ) Conditions affect immune system functioning .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>borderline personality disorder</keyword>
	<keyword>rejection</keyword>
	<keyword>social pain</keyword>
</DOC>